10 years of tamoxifen better to prevent breast cancer, study finds

Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA